| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | neuroligin family protein binding | 2.97e-05 | 5 | 35 | 2 | GO:0097109 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 1.08e-04 | 875 | 35 | 8 | GO:0019904 | |
| GeneOntologyMolecularFunction | phosphorylation-dependent protein binding | 1.33e-04 | 10 | 35 | 2 | GO:0140031 | |
| GeneOntologyMolecularFunction | sodium:phosphate symporter activity | 1.95e-04 | 12 | 35 | 2 | GO:0005436 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 3.83e-04 | 81 | 35 | 3 | GO:0015370 | |
| GeneOntologyMolecularFunction | structural molecule activity | 7.73e-04 | 891 | 35 | 7 | GO:0005198 | |
| GeneOntologyMolecularFunction | phosphate transmembrane transporter activity | 8.04e-04 | 24 | 35 | 2 | GO:0005315 | |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 8.04e-04 | 24 | 35 | 2 | GO:0008093 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.18e-03 | 119 | 35 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 1.29e-03 | 123 | 35 | 3 | GO:0030165 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.52e-03 | 130 | 35 | 3 | GO:0005200 | |
| GeneOntologyMolecularFunction | spectrin binding | 1.62e-03 | 34 | 35 | 2 | GO:0030507 | |
| GeneOntologyMolecularFunction | symporter activity | 2.28e-03 | 150 | 35 | 3 | GO:0015293 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 2.46e-03 | 42 | 35 | 2 | GO:0098918 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 2.84e-03 | 162 | 35 | 3 | GO:0099106 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 3.30e-03 | 171 | 35 | 3 | GO:0015103 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 3.30e-03 | 171 | 35 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 3.36e-03 | 172 | 35 | 3 | GO:0044325 | |
| GeneOntologyMolecularFunction | channel regulator activity | 3.47e-03 | 174 | 35 | 3 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 3.64e-03 | 177 | 35 | 3 | GO:0141108 | |
| GeneOntologyMolecularFunction | calcium channel regulator activity | 4.03e-03 | 54 | 35 | 2 | GO:0005246 | |
| GeneOntologyMolecularFunction | zinc ion binding | 4.15e-03 | 891 | 35 | 6 | GO:0008270 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 5.55e-03 | 206 | 35 | 3 | GO:0140030 | |
| GeneOntologyBiologicalProcess | vocal learning | 1.56e-07 | 7 | 35 | 3 | GO:0042297 | |
| GeneOntologyBiologicalProcess | imitative learning | 1.56e-07 | 7 | 35 | 3 | GO:0098596 | |
| GeneOntologyBiologicalProcess | observational learning | 3.73e-07 | 9 | 35 | 3 | GO:0098597 | |
| GeneOntologyBiologicalProcess | regulation of transporter activity | 5.95e-07 | 299 | 35 | 7 | GO:0032409 | |
| GeneOntologyBiologicalProcess | learned vocalization behavior or vocal learning | 7.32e-07 | 11 | 35 | 3 | GO:0098598 | |
| GeneOntologyBiologicalProcess | auditory behavior | 1.61e-06 | 14 | 35 | 3 | GO:0031223 | |
| GeneOntologyBiologicalProcess | guanylate kinase-associated protein clustering | 2.80e-06 | 2 | 35 | 2 | GO:0097117 | |
| GeneOntologyBiologicalProcess | mechanosensory behavior | 2.99e-06 | 17 | 35 | 3 | GO:0007638 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 3.42e-06 | 559 | 35 | 8 | GO:0042391 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transporter activity | 4.14e-06 | 256 | 35 | 6 | GO:0032412 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transporter activity | 5.16e-06 | 266 | 35 | 6 | GO:0022898 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 8.84e-06 | 24 | 35 | 3 | GO:0071625 | |
| GeneOntologyBiologicalProcess | neuroligin clustering involved in postsynaptic membrane assembly | 1.67e-05 | 4 | 35 | 2 | GO:0097118 | |
| GeneOntologyBiologicalProcess | positive regulation of ion transmembrane transporter activity | 2.15e-05 | 97 | 35 | 4 | GO:0032414 | |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 2.58e-05 | 34 | 35 | 3 | GO:0097107 | |
| GeneOntologyBiologicalProcess | presynaptic active zone assembly | 2.79e-05 | 5 | 35 | 2 | GO:1904071 | |
| GeneOntologyBiologicalProcess | gephyrin clustering involved in postsynaptic density assembly | 2.79e-05 | 5 | 35 | 2 | GO:0097116 | |
| GeneOntologyBiologicalProcess | positive regulation of transporter activity | 3.17e-05 | 107 | 35 | 4 | GO:0032411 | |
| GeneOntologyBiologicalProcess | response to auditory stimulus | 3.34e-05 | 37 | 35 | 3 | GO:0010996 | |
| GeneOntologyBiologicalProcess | regulation of grooming behavior | 4.18e-05 | 6 | 35 | 2 | GO:2000821 | |
| GeneOntologyBiologicalProcess | NMDA glutamate receptor clustering | 4.18e-05 | 6 | 35 | 2 | GO:0097114 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transport | 5.01e-05 | 589 | 35 | 7 | GO:0034762 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 5.65e-05 | 44 | 35 | 3 | GO:0098698 | |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 6.46e-05 | 46 | 35 | 3 | GO:1904861 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC5A11 SLC34A2 HAVCR1 CBARP DMD ANK2 ANK3 SLC34A1 SHANK3 GABRR3 | 6.56e-05 | 1374 | 35 | 10 | GO:0006811 |
| GeneOntologyBiologicalProcess | regulation of cation channel activity | 8.55e-05 | 138 | 35 | 4 | GO:2001257 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane transport | 9.18e-05 | 273 | 35 | 5 | GO:0034764 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 9.51e-05 | 275 | 35 | 5 | GO:0006814 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor activity | 1.17e-04 | 56 | 35 | 3 | GO:0099601 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane organization | 1.17e-04 | 56 | 35 | 3 | GO:0001941 | |
| GeneOntologyBiologicalProcess | presynaptic active zone organization | 1.25e-04 | 10 | 35 | 2 | GO:1990709 | |
| GeneOntologyBiologicalProcess | postsynaptic density organization | 1.30e-04 | 58 | 35 | 3 | GO:0097106 | |
| GeneOntologyBiologicalProcess | postsynaptic density protein 95 clustering | 1.52e-04 | 11 | 35 | 2 | GO:0097119 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 1.52e-04 | 11 | 35 | 2 | GO:0097104 | |
| GeneOntologyBiologicalProcess | intracellular phosphate ion homeostasis | 1.52e-04 | 11 | 35 | 2 | GO:0030643 | |
| GeneOntologyBiologicalProcess | membrane assembly | 1.74e-04 | 64 | 35 | 3 | GO:0071709 | |
| GeneOntologyBiologicalProcess | cell junction organization | 1.81e-04 | 974 | 35 | 8 | GO:0034330 | |
| GeneOntologyBiologicalProcess | cell junction maintenance | 1.82e-04 | 65 | 35 | 3 | GO:0034331 | |
| GeneOntologyBiologicalProcess | sodium-dependent phosphate transport | 2.16e-04 | 13 | 35 | 2 | GO:0044341 | |
| GeneOntologyBiologicalProcess | metal ion transport | 2.17e-04 | 1000 | 35 | 8 | GO:0030001 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization organization | 2.36e-04 | 71 | 35 | 3 | GO:0099084 | |
| GeneOntologyBiologicalProcess | membrane biogenesis | 2.57e-04 | 73 | 35 | 3 | GO:0044091 | |
| GeneOntologyBiologicalProcess | social behavior | 2.67e-04 | 74 | 35 | 3 | GO:0035176 | |
| GeneOntologyBiologicalProcess | biological process involved in intraspecies interaction between organisms | 2.89e-04 | 76 | 35 | 3 | GO:0051703 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transmembrane transport | 3.04e-04 | 192 | 35 | 4 | GO:0034767 | |
| GeneOntologyBiologicalProcess | localization within membrane | 3.29e-04 | 798 | 35 | 7 | GO:0051668 | |
| GeneOntologyBiologicalProcess | positive regulation of sodium ion transmembrane transporter activity | 3.31e-04 | 16 | 35 | 2 | GO:2000651 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 3.31e-04 | 16 | 35 | 2 | GO:0007158 | |
| GeneOntologyBiologicalProcess | receptor clustering | 3.75e-04 | 83 | 35 | 3 | GO:0043113 | |
| GeneOntologyBiologicalProcess | adult behavior | 3.76e-04 | 203 | 35 | 4 | GO:0030534 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 4.12e-04 | 208 | 35 | 4 | GO:0035725 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 4.30e-04 | 87 | 35 | 3 | GO:0086001 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | 4.53e-04 | 1115 | 35 | 8 | GO:0034220 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle cycle | 4.70e-04 | 19 | 35 | 2 | GO:0098693 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transporter activity | 5.07e-04 | 92 | 35 | 3 | GO:1901019 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase C signaling | 5.21e-04 | 20 | 35 | 2 | GO:0090036 | |
| GeneOntologyBiologicalProcess | postsynapse assembly | 5.23e-04 | 93 | 35 | 3 | GO:0099068 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | 5.79e-04 | 1157 | 35 | 8 | GO:0006812 | |
| GeneOntologyBiologicalProcess | neurotransmitter-gated ion channel clustering | 6.33e-04 | 22 | 35 | 2 | GO:0072578 | |
| GeneOntologyBiologicalProcess | positive regulation of sodium ion transmembrane transport | 6.33e-04 | 22 | 35 | 2 | GO:1902307 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 6.33e-04 | 22 | 35 | 2 | GO:0010881 | |
| GeneOntologyBiologicalProcess | synaptic vesicle clustering | 6.33e-04 | 22 | 35 | 2 | GO:0097091 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transport | 6.49e-04 | 417 | 35 | 5 | GO:0034765 | |
| GeneOntologyBiologicalProcess | cellular component maintenance | 6.66e-04 | 101 | 35 | 3 | GO:0043954 | |
| GeneOntologyBiologicalProcess | membrane depolarization during cardiac muscle cell action potential | 6.92e-04 | 23 | 35 | 2 | GO:0086012 | |
| GeneOntologyBiologicalProcess | phosphate ion homeostasis | 6.92e-04 | 23 | 35 | 2 | GO:0055062 | |
| GeneOntologyBiologicalProcess | membrane organization | 7.42e-04 | 914 | 35 | 7 | GO:0061024 | |
| GeneOntologyBiologicalProcess | grooming behavior | 7.54e-04 | 24 | 35 | 2 | GO:0007625 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 7.85e-04 | 247 | 35 | 4 | GO:0009612 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane potential | 8.19e-04 | 25 | 35 | 2 | GO:0045838 | |
| GeneOntologyBiologicalProcess | response to magnesium ion | 8.19e-04 | 25 | 35 | 2 | GO:0032026 | |
| GeneOntologyBiologicalProcess | regulation of AMPA receptor activity | 8.19e-04 | 25 | 35 | 2 | GO:2000311 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | 8.28e-04 | 931 | 35 | 7 | GO:0098916 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | 8.28e-04 | 931 | 35 | 7 | GO:0007268 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | 8.71e-04 | 939 | 35 | 7 | GO:0099537 | |
| GeneOntologyBiologicalProcess | synapse organization | 9.36e-04 | 685 | 35 | 6 | GO:0050808 | |
| GeneOntologyBiologicalProcess | protein localization to synapse | 9.70e-04 | 115 | 35 | 3 | GO:0035418 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by calcium ion signaling | 1.03e-03 | 28 | 35 | 2 | GO:0010882 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 1.03e-03 | 266 | 35 | 4 | GO:0043270 | |
| GeneOntologyBiologicalProcess | protein localization to membrane | 1.09e-03 | 705 | 35 | 6 | GO:0072657 | |
| GeneOntologyBiologicalProcess | synaptic signaling | 1.09e-03 | 976 | 35 | 7 | GO:0099536 | |
| GeneOntologyBiologicalProcess | phosphate ion transport | 1.26e-03 | 31 | 35 | 2 | GO:0006817 | |
| GeneOntologyBiologicalProcess | regulation of system process | 1.34e-03 | 734 | 35 | 6 | GO:0044057 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 1.38e-03 | 130 | 35 | 3 | GO:0060079 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 1.39e-03 | 1017 | 35 | 7 | GO:0098660 | |
| GeneOntologyBiologicalProcess | regulation of signaling receptor activity | 1.41e-03 | 131 | 35 | 3 | GO:0010469 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1.43e-03 | 33 | 35 | 2 | GO:0010880 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 1.70e-03 | 36 | 35 | 2 | GO:0086010 | |
| GeneOntologyBiologicalProcess | synapse assembly | 1.77e-03 | 308 | 35 | 4 | GO:0007416 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1.79e-03 | 37 | 35 | 2 | GO:0014808 | |
| GeneOntologyCellularComponent | synaptic membrane | 5.30e-06 | 583 | 36 | 8 | GO:0097060 | |
| GeneOntologyCellularComponent | costamere | 7.06e-06 | 22 | 36 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 8.66e-06 | 164 | 36 | 5 | GO:0098982 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 2.62e-05 | 523 | 36 | 7 | GO:0098984 | |
| GeneOntologyCellularComponent | Z disc | 1.29e-04 | 151 | 36 | 4 | GO:0030018 | |
| GeneOntologyCellularComponent | brush border | 1.32e-04 | 152 | 36 | 4 | GO:0005903 | |
| GeneOntologyCellularComponent | asymmetric synapse | 1.49e-04 | 477 | 36 | 6 | GO:0032279 | |
| GeneOntologyCellularComponent | apical plasma membrane | 1.67e-04 | 487 | 36 | 6 | GO:0016324 | |
| GeneOntologyCellularComponent | I band | 1.85e-04 | 166 | 36 | 4 | GO:0031674 | |
| GeneOntologyCellularComponent | postsynapse | 2.75e-04 | 1018 | 36 | 8 | GO:0098794 | |
| GeneOntologyCellularComponent | brush border membrane | 3.92e-04 | 83 | 36 | 3 | GO:0031526 | |
| GeneOntologyCellularComponent | apical part of cell | 4.75e-04 | 592 | 36 | 6 | GO:0045177 | |
| GeneOntologyCellularComponent | cell surface | 4.95e-04 | 1111 | 36 | 8 | GO:0009986 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 5.68e-04 | 223 | 36 | 4 | GO:0098862 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 6.12e-04 | 405 | 36 | 5 | GO:0045211 | |
| GeneOntologyCellularComponent | cell projection membrane | 8.10e-04 | 431 | 36 | 5 | GO:0031253 | |
| GeneOntologyCellularComponent | excitatory synapse | 8.23e-04 | 107 | 36 | 3 | GO:0060076 | |
| GeneOntologyCellularComponent | sarcomere | 8.58e-04 | 249 | 36 | 4 | GO:0030017 | |
| GeneOntologyCellularComponent | Golgi lumen | 8.69e-04 | 109 | 36 | 3 | GO:0005796 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 9.58e-04 | 1228 | 36 | 8 | GO:0036477 | |
| GeneOntologyCellularComponent | postsynaptic density | 9.93e-04 | 451 | 36 | 5 | GO:0014069 | |
| GeneOntologyCellularComponent | myofibril | 1.21e-03 | 273 | 36 | 4 | GO:0030016 | |
| GeneOntologyCellularComponent | inhibitory synapse | 1.30e-03 | 31 | 36 | 2 | GO:0060077 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.51e-03 | 290 | 36 | 4 | GO:0043292 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.61e-03 | 503 | 36 | 5 | GO:0099572 | |
| GeneOntologyCellularComponent | presynaptic active zone | 1.82e-03 | 141 | 36 | 3 | GO:0048786 | |
| GeneOntologyCellularComponent | dendrite | 3.19e-03 | 858 | 36 | 6 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 3.23e-03 | 860 | 36 | 6 | GO:0097447 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 3.58e-03 | 179 | 36 | 3 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 3.58e-03 | 179 | 36 | 3 | GO:0030672 | |
| GeneOntologyCellularComponent | A band | 3.62e-03 | 52 | 36 | 2 | GO:0031672 | |
| GeneOntologyCellularComponent | presynapse | 3.74e-03 | 886 | 36 | 6 | GO:0098793 | |
| GeneOntologyCellularComponent | sarcolemma | 4.23e-03 | 190 | 36 | 3 | GO:0042383 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 4.83e-03 | 934 | 36 | 6 | GO:0048471 | |
| GeneOntologyCellularComponent | intercalated disc | 6.12e-03 | 68 | 36 | 2 | GO:0014704 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 7.98e-03 | 78 | 36 | 2 | GO:0048787 | |
| GeneOntologyCellularComponent | T-tubule | 8.17e-03 | 79 | 36 | 2 | GO:0030315 | |
| GeneOntologyCellularComponent | dendritic spine | 8.26e-03 | 242 | 36 | 3 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 8.73e-03 | 247 | 36 | 3 | GO:0044309 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.05e-02 | 90 | 36 | 2 | GO:0016328 | |
| MousePheno | abnormal CNS synaptic transmission | 8.04e-06 | 985 | 27 | 10 | MP:0002206 | |
| MousePheno | abnormal synaptic transmission | 1.67e-05 | 1070 | 27 | 10 | MP:0003635 | |
| MousePheno | abnormal synaptic physiology | 1.76e-05 | 1076 | 27 | 10 | MP:0021009 | |
| MousePheno | decreased stereotypic behavior | 9.99e-05 | 8 | 27 | 2 | MP:0003908 | |
| Domain | Na_Pi_cotrans | 1.02e-05 | 3 | 35 | 2 | PF02690 | |
| Domain | Na/Pi_transpt | 1.02e-05 | 3 | 35 | 2 | IPR003841 | |
| Domain | Syndecan | 7.12e-05 | 7 | 35 | 2 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 7.12e-05 | 7 | 35 | 2 | IPR027789 | |
| Domain | ANK_REPEAT | 1.02e-04 | 253 | 35 | 5 | PS50088 | |
| Domain | ANK_REP_REGION | 1.04e-04 | 254 | 35 | 5 | PS50297 | |
| Domain | ZU5 | 1.22e-04 | 9 | 35 | 2 | SM00218 | |
| Domain | ZU5 | 1.52e-04 | 10 | 35 | 2 | PS51145 | |
| Domain | ZU5_dom | 2.23e-04 | 12 | 35 | 2 | IPR000906 | |
| Domain | TIL | 2.23e-04 | 12 | 35 | 2 | PF01826 | |
| Domain | C8 | 2.23e-04 | 12 | 35 | 2 | PF08742 | |
| Domain | ZU5 | 2.23e-04 | 12 | 35 | 2 | PF00791 | |
| Domain | Unchr_dom_Cys-rich | 2.63e-04 | 13 | 35 | 2 | IPR014853 | |
| Domain | C8 | 2.63e-04 | 13 | 35 | 2 | SM00832 | |
| Domain | SEA | 3.06e-04 | 14 | 35 | 2 | SM00200 | |
| Domain | Neurexin-like | 3.06e-04 | 14 | 35 | 2 | IPR003585 | |
| Domain | 4.1m | 3.06e-04 | 14 | 35 | 2 | SM00294 | |
| Domain | TIL_dom | 3.06e-04 | 14 | 35 | 2 | IPR002919 | |
| Domain | - | 3.53e-04 | 15 | 35 | 2 | 3.30.70.960 | |
| Domain | VWFD | 4.03e-04 | 16 | 35 | 2 | PS51233 | |
| Domain | VWD | 4.03e-04 | 16 | 35 | 2 | SM00216 | |
| Domain | VWF_type-D | 4.03e-04 | 16 | 35 | 2 | IPR001846 | |
| Domain | VWD | 4.03e-04 | 16 | 35 | 2 | PF00094 | |
| Domain | VWC_out | 5.72e-04 | 19 | 35 | 2 | SM00215 | |
| Domain | Ank_2 | 6.76e-04 | 215 | 35 | 4 | PF12796 | |
| Domain | SEA | 7.70e-04 | 22 | 35 | 2 | PF01390 | |
| Domain | SEA | 8.42e-04 | 23 | 35 | 2 | PS50024 | |
| Domain | SEA_dom | 8.42e-04 | 23 | 35 | 2 | IPR000082 | |
| Domain | EGF_3 | 9.42e-04 | 235 | 35 | 4 | PS50026 | |
| Domain | EGF | 9.42e-04 | 235 | 35 | 4 | SM00181 | |
| Domain | - | 1.15e-03 | 248 | 35 | 4 | 1.25.40.20 | |
| Domain | DEATH | 1.16e-03 | 27 | 35 | 2 | SM00005 | |
| Domain | EGF-like_dom | 1.17e-03 | 249 | 35 | 4 | IPR000742 | |
| Domain | ANK | 1.20e-03 | 251 | 35 | 4 | SM00248 | |
| Domain | Ankyrin_rpt-contain_dom | 1.26e-03 | 254 | 35 | 4 | IPR020683 | |
| Domain | EGF_1 | 1.27e-03 | 255 | 35 | 4 | PS00022 | |
| Domain | EGF-like_CS | 1.39e-03 | 261 | 35 | 4 | IPR013032 | |
| Domain | Ankyrin_rpt | 1.41e-03 | 262 | 35 | 4 | IPR002110 | |
| Domain | EGF_2 | 1.47e-03 | 265 | 35 | 4 | PS01186 | |
| Domain | EGF | 1.68e-03 | 126 | 35 | 3 | PF00008 | |
| Domain | Death | 1.74e-03 | 33 | 35 | 2 | PF00531 | |
| Domain | VWFC_1 | 2.07e-03 | 36 | 35 | 2 | PS01208 | |
| Domain | Death_domain | 2.30e-03 | 38 | 35 | 2 | IPR000488 | |
| Domain | DEATH_DOMAIN | 2.30e-03 | 38 | 35 | 2 | PS50017 | |
| Domain | LAM_G_DOMAIN | 2.30e-03 | 38 | 35 | 2 | PS50025 | |
| Domain | VWC | 2.30e-03 | 38 | 35 | 2 | SM00214 | |
| Domain | VWFC_2 | 2.30e-03 | 38 | 35 | 2 | PS50184 | |
| Domain | Laminin_G_2 | 2.54e-03 | 40 | 35 | 2 | PF02210 | |
| Domain | VWF_dom | 2.80e-03 | 42 | 35 | 2 | IPR001007 | |
| Domain | LamG | 3.07e-03 | 44 | 35 | 2 | SM00282 | |
| Domain | Laminin_G | 5.28e-03 | 58 | 35 | 2 | IPR001791 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 3.86e-06 | 16 | 28 | 3 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 4.68e-06 | 17 | 28 | 3 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 9.11e-06 | 21 | 28 | 3 | MM15706 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.21e-05 | 23 | 28 | 3 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 1.77e-05 | 26 | 28 | 3 | M27483 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 3.35e-05 | 32 | 28 | 3 | MM15326 | |
| Pathway | REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS | 3.79e-05 | 5 | 28 | 2 | M27345 | |
| Pathway | REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS | 3.79e-05 | 5 | 28 | 2 | MM15085 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.23e-04 | 60 | 28 | 3 | MM15636 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.45e-04 | 62 | 28 | 3 | M546 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 3.09e-04 | 67 | 28 | 3 | MM15327 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.23e-04 | 68 | 28 | 3 | M27303 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 9.38e-04 | 23 | 28 | 2 | MM15279 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 9.69e-04 | 99 | 28 | 3 | M27474 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.28e-03 | 109 | 28 | 3 | MM15164 | |
| Pathway | WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS | 1.29e-03 | 27 | 28 | 2 | M45550 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.35e-03 | 111 | 28 | 3 | M27416 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.41e-03 | 250 | 28 | 4 | M27554 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 1.60e-03 | 30 | 28 | 2 | M27566 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.71e-03 | 31 | 28 | 2 | M877 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 1.93e-03 | 33 | 28 | 2 | M39875 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 2.62e-03 | 140 | 28 | 3 | M27484 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.78e-03 | 143 | 28 | 3 | M27275 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 4.09e-03 | 335 | 28 | 4 | MM14503 | |
| Pubmed | An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan. | 1.02e-08 | 5 | 36 | 3 | 19109891 | |
| Pubmed | 8.52e-08 | 9 | 36 | 3 | 21356198 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 2.58e-07 | 430 | 36 | 7 | 35044719 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 8.22e-07 | 18 | 36 | 3 | 18834073 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 28513807 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 30709877 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 11781319 | ||
| Pubmed | Structural basis of diverse membrane target recognitions by ankyrins. | 1.04e-06 | 2 | 36 | 2 | 25383926 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 17574207 | ||
| Pubmed | Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin. | 1.04e-06 | 2 | 36 | 2 | 1621094 | |
| Pubmed | Type II Na+-Pi cotransporters in osteoblast mineral formation: regulation by inorganic phosphate. | 1.04e-06 | 2 | 36 | 2 | 17310099 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 26595880 | ||
| Pubmed | 1.29e-06 | 1431 | 36 | 10 | 37142655 | ||
| Pubmed | Cbln1 regulates axon growth and guidance in multiple neural regions. | 1.55e-06 | 22 | 36 | 3 | 36395107 | |
| Pubmed | Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior. | 3.12e-06 | 3 | 36 | 2 | 34133920 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 38891114 | ||
| Pubmed | Expression of renal and intestinal Na/Pi cotransporters in the absence of GABARAP. | 3.12e-06 | 3 | 36 | 2 | 20354864 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 11880379 | ||
| Pubmed | Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. | 3.12e-06 | 3 | 36 | 2 | 21424692 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 27230679 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 30858964 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 28013231 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 15611082 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 16406382 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 31812984 | ||
| Pubmed | Human ankyrins and their contribution to disease biology: An update. | 3.12e-06 | 3 | 36 | 2 | 33410423 | |
| Pubmed | Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. | 3.12e-06 | 3 | 36 | 2 | 12036300 | |
| Pubmed | β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. | 3.12e-06 | 3 | 36 | 2 | 26213384 | |
| Pubmed | Neurexin gene family variants as risk factors for autism spectrum disorder. | 3.12e-06 | 3 | 36 | 2 | 29045040 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 31005376 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 38571813 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 35173587 | ||
| Pubmed | Dopaminergic neurons establish a distinctive axonal arbor with a majority of non-synaptic terminals. | 3.12e-06 | 3 | 36 | 2 | 34320240 | |
| Pubmed | Upregulation of the Na⁺-coupled phosphate cotransporters NaPi-IIa and NaPi-IIb by B-RAF. | 3.12e-06 | 3 | 36 | 2 | 24258620 | |
| Pubmed | Neurexins are differentially expressed in the embryonic nervous system of mice. | 3.12e-06 | 3 | 36 | 2 | 7722633 | |
| Pubmed | Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals. | 3.12e-06 | 3 | 36 | 2 | 26446217 | |
| Pubmed | Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. | 3.12e-06 | 3 | 36 | 2 | 11944992 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 33058888 | ||
| Pubmed | Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. | 3.12e-06 | 3 | 36 | 2 | 17035546 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 9448462 | ||
| Pubmed | Deletion of α-neurexin II results in autism-related behaviors in mice. | 3.12e-06 | 3 | 36 | 2 | 25423136 | |
| Pubmed | Ankyrin-dependent Na+ channel clustering prevents neuromuscular synapse fatigue. | 3.12e-06 | 3 | 36 | 2 | 34289389 | |
| Pubmed | 4.11e-06 | 233 | 36 | 5 | 29518331 | ||
| Pubmed | 5.44e-06 | 33 | 36 | 3 | 36522157 | ||
| Pubmed | Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins. | 6.24e-06 | 4 | 36 | 2 | 14983056 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 32706374 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 29398136 | ||
| Pubmed | GluRδ2 assembles four neurexins into trans-synaptic triad to trigger synapse formation. | 6.24e-06 | 4 | 36 | 2 | 22457515 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 19233126 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 8786425 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 21186323 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 17347997 | ||
| Pubmed | Neurexins cluster Ca2+ channels within the presynaptic active zone. | 6.24e-06 | 4 | 36 | 2 | 32134527 | |
| Pubmed | Autism-associated miR-873 regulates ARID1B, SHANK3 and NRXN2 involved in neurodevelopment. | 6.24e-06 | 4 | 36 | 2 | 33262327 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 35385735 | ||
| Pubmed | Neurexins regulate presynaptic GABAB-receptors at central synapses. | 6.24e-06 | 4 | 36 | 2 | 33888718 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 25950943 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 28472659 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 36709330 | ||
| Pubmed | Glial ankyrins facilitate paranodal axoglial junction assembly. | 1.04e-05 | 5 | 36 | 2 | 25362471 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 20537373 | ||
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 1.04e-05 | 5 | 36 | 2 | 18923512 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 9223334 | ||
| Pubmed | 1.28e-05 | 777 | 36 | 7 | 35844135 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 12149647 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 19110483 | ||
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 1.56e-05 | 6 | 36 | 2 | 12827191 | |
| Pubmed | Structures, alternative splicing, and neurexin binding of multiple neuroligins. | 1.56e-05 | 6 | 36 | 2 | 8576240 | |
| Pubmed | In vivo assembly of the axon initial segment in motor neurons. | 1.56e-05 | 6 | 36 | 2 | 23728480 | |
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 30683685 | ||
| Pubmed | Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice. | 2.18e-05 | 7 | 36 | 2 | 7495297 | |
| Pubmed | Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway. | 2.91e-05 | 8 | 36 | 2 | 28826662 | |
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 2.91e-05 | 8 | 36 | 2 | 30871858 | |
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 37591863 | ||
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 12115694 | ||
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 23010509 | ||
| Pubmed | Potent and specific Atg8-targeting autophagy inhibitory peptides from giant ankyrins. | 3.73e-05 | 9 | 36 | 2 | 29867141 | |
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 34919427 | ||
| Pubmed | Expression of Phosphate Transporters during Dental Mineralization. | 3.73e-05 | 9 | 36 | 2 | 28892649 | |
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 9707552 | ||
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 4.66e-05 | 10 | 36 | 2 | 22159418 | |
| Pubmed | 5.05e-05 | 963 | 36 | 7 | 28671696 | ||
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 10995443 | ||
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 32973045 | ||
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 26403076 | ||
| Pubmed | 6.83e-05 | 12 | 36 | 2 | 28700933 | ||
| Pubmed | Advancing the understanding of autism disease mechanisms through genetics. | 8.07e-05 | 13 | 36 | 2 | 27050589 | |
| Pubmed | Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation. | 8.07e-05 | 13 | 36 | 2 | 18641643 | |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 8.07e-05 | 13 | 36 | 2 | 31427429 | |
| Pubmed | 8.64e-05 | 1049 | 36 | 7 | 27880917 | ||
| Pubmed | The contribution of rare and common variants in 30 genes to risk nicotine dependence. | 9.41e-05 | 14 | 36 | 2 | 25450229 | |
| Pubmed | TLR3 downregulates expression of schizophrenia gene Disc1 via MYD88 to control neuronal morphology. | 9.41e-05 | 14 | 36 | 2 | 27979975 | |
| Pubmed | 1.06e-04 | 1084 | 36 | 7 | 11544199 | ||
| Pubmed | Ankyrin-G regulated epithelial phenotype is required for mouse lens morphogenesis and growth. | 1.08e-04 | 15 | 36 | 2 | 30562487 | |
| Pubmed | 1.24e-04 | 16 | 36 | 2 | 24470103 | ||
| Pubmed | Tissue distribution, ontogeny, and hormonal regulation of xenobiotic transporters in mouse kidneys. | 1.24e-04 | 16 | 36 | 2 | 19679677 | |
| Pubmed | 1.30e-04 | 251 | 36 | 4 | 27507650 | ||
| Pubmed | 1.40e-04 | 17 | 36 | 2 | 27779093 | ||
| Pubmed | 1.44e-04 | 1139 | 36 | 7 | 36417873 | ||
| Pubmed | 1.58e-04 | 18 | 36 | 2 | 37321992 | ||
| Interaction | ANK2 interactions | 2.18e-05 | 98 | 34 | 4 | int:ANK2 | |
| Interaction | ZAN interactions | 2.75e-05 | 5 | 34 | 2 | int:ZAN | |
| Interaction | RGS14 interactions | 4.82e-05 | 240 | 34 | 5 | int:RGS14 | |
| Interaction | KCTD13 interactions | 6.85e-05 | 1394 | 34 | 10 | int:KCTD13 | |
| GeneFamily | CD molecules|Mucins | 2.32e-08 | 21 | 27 | 4 | 648 | |
| GeneFamily | Ankyrin repeat domain containing | 4.31e-04 | 242 | 27 | 4 | 403 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | 3.12e-05 | 450 | 36 | 6 | M39072 | |
| Coexpression | HEVNER_CORTICAL_PLATE_POSTMITOTIC_NEURONS | 3.59e-05 | 136 | 36 | 4 | MM407 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | 3.74e-05 | 465 | 36 | 6 | M39066 | |
| Coexpression | NABA_ECM_AFFILIATED | 8.56e-05 | 170 | 36 | 4 | M5880 | |
| Coexpression | HU_FETAL_RETINA_AMACRINE | 9.36e-05 | 64 | 36 | 3 | M39261 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | 1.03e-04 | 1106 | 36 | 8 | M39071 | |
| Coexpression | GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_DN | 1.54e-04 | 198 | 36 | 4 | M8355 | |
| Coexpression | GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_UP | 1.54e-04 | 198 | 36 | 4 | M8377 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 9.12e-05 | 688 | 34 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.22e-04 | 721 | 34 | 7 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.23e-04 | 722 | 34 | 7 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.32e-04 | 730 | 34 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.34e-04 | 732 | 34 | 7 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.47e-04 | 743 | 34 | 7 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.52e-04 | 747 | 34 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.52e-04 | 747 | 34 | 7 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_500 | 2.63e-04 | 78 | 34 | 3 | gudmap_developingKidney_e15.5_Cap mesenchyme_500_k5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-07 | 184 | 36 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-07 | 184 | 36 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-07 | 184 | 36 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 5.56e-07 | 200 | 36 | 5 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.29e-05 | 179 | 36 | 4 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.29e-05 | 179 | 36 | 4 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.32e-05 | 180 | 36 | 4 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.32e-05 | 180 | 36 | 4 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 1.41e-05 | 183 | 36 | 4 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-05 | 184 | 36 | 4 | ed7a8e79e5723a5f5a03f542203d9e50bdef5f50 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.44e-05 | 184 | 36 | 4 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 1.44e-05 | 184 | 36 | 4 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.47e-05 | 185 | 36 | 4 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-05 | 185 | 36 | 4 | f607b6ee579562e2f92103fa5c7053df0170a229 | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-05 | 185 | 36 | 4 | 317f2c854f00aa5957319b818c85eeed7d72ec7f | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-05 | 185 | 36 | 4 | 7bb8fdfe04f85d25056380ec58222366de323a21 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.57e-05 | 188 | 36 | 4 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.63e-05 | 190 | 36 | 4 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.67e-05 | 191 | 36 | 4 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.67e-05 | 191 | 36 | 4 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 193 | 36 | 4 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 193 | 36 | 4 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 193 | 36 | 4 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.74e-05 | 193 | 36 | 4 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | 21-Trachea-Epithelial-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 1.74e-05 | 193 | 36 | 4 | 9a8bb44a37f3202e3123a6680bd5545dc91a6d40 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.77e-05 | 194 | 36 | 4 | 7a66bd7d4fc9c6db861cedd2487f241e406869d1 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.77e-05 | 194 | 36 | 4 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 1.77e-05 | 194 | 36 | 4 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.81e-05 | 195 | 36 | 4 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-05 | 195 | 36 | 4 | fc2a1d84b3d013e5cb9e7b9cdd740e4010897d20 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.81e-05 | 195 | 36 | 4 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 196 | 36 | 4 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 196 | 36 | 4 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.88e-05 | 197 | 36 | 4 | b2f4d7c301c0b24003374923b31d6d058e40b213 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-midbrain/hindbrain_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.88e-05 | 197 | 36 | 4 | c7078f6fcf27319ba8c5ebe700bcae7f1e7e39c1 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 1.96e-05 | 199 | 36 | 4 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.96e-05 | 199 | 36 | 4 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 1.96e-05 | 199 | 36 | 4 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.00e-05 | 200 | 36 | 4 | 979258173b82f37aeaaedd53b4a527da1dbe1b80 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.00e-05 | 200 | 36 | 4 | 60b86c4a4e247b2673d31b085b440a6e574393bb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Cortical_neuron|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.00e-05 | 200 | 36 | 4 | db2dbd31dd02c0d1c1070ed5548ce949227e4775 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.00e-05 | 200 | 36 | 4 | f5bc7d30aa03dd0f95eb64255bd1a2543be8d327 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Reln_(Cajal-Retzius)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.12e-04 | 116 | 36 | 3 | 1bfd3b0ec4cb5a04c6dfe7861a544eb277e473a3 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Reln_(Cajal-Retzius)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.12e-04 | 116 | 36 | 3 | a3dcd18807d14e207438f321be62797384fd3907 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-04 | 116 | 36 | 3 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.12e-04 | 116 | 36 | 3 | 685484ea4cbefb5aff5f0cd999fdfadc5a5676e1 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.30e-04 | 122 | 36 | 3 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | LA-10._Endothelium_II|LA / Chamber and Cluster_Paper | 1.72e-04 | 134 | 36 | 3 | 048fa6ccf305d22d9a53db4ab385f39f558010d8 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.79e-04 | 136 | 36 | 3 | 27a41463e6f16deb5b1d4f17fefded9959038c07 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.79e-04 | 136 | 36 | 3 | 88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11 | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.25e-04 | 147 | 36 | 3 | aba44c7057096483c4293a7ebcf8ccc8baed0231 | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|LA / Chamber and Cluster_Paper | 2.25e-04 | 147 | 36 | 3 | 8970eb6b82589f39439c61a57d999661ec8342de | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-04 | 147 | 36 | 3 | c8e5bdc3538089acd35a4b41390afaec0ac6d1aa | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.49e-04 | 152 | 36 | 3 | 00d5503d462cfa009fb4cac79ecee11725a18b9a | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.49e-04 | 152 | 36 | 3 | fc9472bc19f997103da535b035105f01429cb08e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-04 | 153 | 36 | 3 | 499670e716fc85ce76630fc813cec86f8419f2a1 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.58e-04 | 154 | 36 | 3 | 89a60a79d07466d7ad05888d10a72d3b1ab384af | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.58e-04 | 154 | 36 | 3 | f1fea1a87e977221fa125b62287368be9af4987d | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.58e-04 | 154 | 36 | 3 | b5604c0b0b9b283352a3f612f40883b9123475d1 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal-1|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.58e-04 | 154 | 36 | 3 | 160b170a3ade8b246843c9854af332475c047ba0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-04 | 157 | 36 | 3 | c43f2e1ea53b375a7432f17f87cfef3b2261003d | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-Tregs|GI_small-bowel / Manually curated celltypes from each tissue | 2.73e-04 | 157 | 36 | 3 | c44bd530e396b08f16f284e185dcb830843959ea | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 3.16e-04 | 165 | 36 | 3 | 9795ce31689bc63f5a2d68725ef00b23a90c3846 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.28e-04 | 167 | 36 | 3 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.34e-04 | 168 | 36 | 3 | 4e2e4c88ada772e9ba6e72c9ae3a05c063e93318 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.34e-04 | 168 | 36 | 3 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.34e-04 | 168 | 36 | 3 | ee4dab089adef2f47a9d39d91934523331a8b81c | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-5|TCGA-Bladder / Sample_Type by Project: Shred V9 | 3.39e-04 | 169 | 36 | 3 | 9c4e83fe8225d16173a103bf5a57b17d623be923 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.39e-04 | 169 | 36 | 3 | 2456b3e7776e8a2214972be1b4d66a3ca5480ae0 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 170 | 36 | 3 | 3ad9f950b87ee98f025ab9b4a8ed551e6a9b4764 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 172 | 36 | 3 | 62734d231290ca725276dc62faa2ac87bd1b37b8 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.57e-04 | 172 | 36 | 3 | 03a0aff6b7971093a4347b5ed12546d78374c56f | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 173 | 36 | 3 | 0a0cd40bb5f61431fe34758626c8a63ec610a8a5 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 173 | 36 | 3 | 2eb6e9fc3a3654f6f86fbd112e80a18814afd103 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 3.63e-04 | 173 | 36 | 3 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.63e-04 | 173 | 36 | 3 | 5295ed31648abf8edff214cf67cd4769f20f9e6d | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-04 | 174 | 36 | 3 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.70e-04 | 174 | 36 | 3 | 4da79da7a09ee1e345102c5331675ebcdbe56171 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.88e-04 | 177 | 36 | 3 | 2b63f0529ef73e0eede9b7ef1f08b0a0426a9c82 | |
| ToppCell | ILEUM-inflamed-(9)_Enteric_neurons|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.95e-04 | 178 | 36 | 3 | d9142151819afb0dc22bfb32a9c9dba5f553067d | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-04 | 178 | 36 | 3 | 56b19f9c9585538fb8a4c3eea2d132b254cf11ef | |
| ToppCell | (5)_Glands_mucous|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.95e-04 | 178 | 36 | 3 | f0f19b0d78f2cc5df4d4c321a953a6e447d5114a | |
| ToppCell | ILEUM-inflamed-(9)_Neuro_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.95e-04 | 178 | 36 | 3 | 611504b0a9e6318b18fba83787b03f9245c82252 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.01e-04 | 179 | 36 | 3 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_mucous|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.08e-04 | 180 | 36 | 3 | a4118adaf4b09e2ca01b662ed60e7bbf32a24d58 | |
| ToppCell | 5'-Adult-SmallIntestine-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.08e-04 | 180 | 36 | 3 | 5e6e38ee0758ef2342a6a821c78ed24b57bb7b11 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-04 | 180 | 36 | 3 | 0153667e44fdbc3c0d444dcb023069925a2b69a2 | |
| ToppCell | 5'-Adult-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.08e-04 | 180 | 36 | 3 | b88cd7ae922782176c057342d1b9eb9b8e5e7204 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-04 | 180 | 36 | 3 | 40a28b410f46215d6d7cf8a02a18078eb046b5b0 | |
| ToppCell | 5'-Adult-SmallIntestine-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.08e-04 | 180 | 36 | 3 | ebd6e719a03f25155fa8181be19469d04d6d10a6 | |
| ToppCell | 3'_v3-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 4.15e-04 | 181 | 36 | 3 | 66d890a105f955dca91d6e5e6c730d1a68ee9233 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.15e-04 | 181 | 36 | 3 | 098dbb3e0ff531c9720a233123250c1e39a97d4c | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.15e-04 | 181 | 36 | 3 | 1aebb62ed4439db444ee9d30688212b86ee3d9ef | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-04 | 181 | 36 | 3 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative-neuro_NA|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.15e-04 | 181 | 36 | 3 | 6aee2ddee4790250ef3b2ef0038bd9839925c995 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-04 | 181 | 36 | 3 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-04 | 181 | 36 | 3 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | PCW_10-12-Neuronal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.15e-04 | 181 | 36 | 3 | 381b553e2cae65ce6be100662a5f9f963353840c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-04 | 182 | 36 | 3 | e1e58176f533092b6b974ca1ce8b02192a6e193d | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 4.21e-04 | 182 | 36 | 3 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| Computational | Neighborhood of RTN1 | 1.77e-04 | 52 | 23 | 3 | GNF2_RTN1 | |
| Drug | O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate | 1.46e-05 | 211 | 34 | 5 | ctd:C009618 | |
| Drug | enzacamene | 4.00e-05 | 129 | 34 | 4 | ctd:C038939 | |
| Drug | octylmethoxycinnamate | 5.35e-05 | 139 | 34 | 4 | ctd:C118580 | |
| Drug | nalidixic acid | 5.36e-05 | 277 | 34 | 5 | CID000004421 | |
| Drug | arsenic pentoxide | 6.03e-05 | 8 | 34 | 2 | ctd:C042120 | |
| Drug | 3-doxylandrostanol | 7.74e-05 | 9 | 34 | 2 | CID000189075 | |
| Drug | butylparaben | 8.59e-05 | 157 | 34 | 4 | ctd:C038091 | |
| Drug | C7 5 | 9.67e-05 | 10 | 34 | 2 | CID004248455 | |
| Drug | AC1NSPXR | 1.18e-04 | 11 | 34 | 2 | CID005313815 | |
| Drug | 26-nor-25-doxylcholestanol | 1.18e-04 | 11 | 34 | 2 | CID000125890 | |
| Drug | 20,25-diazacholesterol | 1.18e-04 | 11 | 34 | 2 | CID000009402 | |
| Disease | Semantic-Pragmatic Disorder | 7.90e-05 | 11 | 36 | 2 | C0454655 | |
| Disease | Auditory Processing Disorder, Central | 7.90e-05 | 11 | 36 | 2 | C0751257 | |
| Disease | Language Delay | 7.90e-05 | 11 | 36 | 2 | C0023012 | |
| Disease | Language Development Disorders | 7.90e-05 | 11 | 36 | 2 | C0023014 | |
| Disease | Speech Delay | 7.90e-05 | 11 | 36 | 2 | C0241210 | |
| Disease | Autism Spectrum Disorders | 1.54e-04 | 85 | 36 | 3 | C1510586 | |
| Disease | Schizophrenia | 2.19e-04 | 18 | 36 | 2 | cv:C0036341 | |
| Disease | Alzheimer disease, educational attainment | 2.29e-04 | 247 | 36 | 4 | EFO_0011015, MONDO_0004975 | |
| Disease | chronic kidney disease (biomarker_via_orthology) | 5.36e-04 | 28 | 36 | 2 | DOID:784 (biomarker_via_orthology) | |
| Disease | metabolite measurement | 5.61e-04 | 560 | 36 | 5 | EFO_0004725 | |
| Disease | response to aromatase inhibitor | 7.01e-04 | 32 | 36 | 2 | GO_0061477 | |
| Disease | anti-GAD65 autoimmune neurological syndromes | 8.40e-04 | 35 | 36 | 2 | EFO_0803379 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 8.45e-04 | 152 | 36 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | sex interaction measurement, Crohn's disease | 9.38e-04 | 37 | 36 | 2 | EFO_0000384, EFO_0008343 | |
| Disease | Proteinuria | 1.27e-03 | 43 | 36 | 2 | C0033687 | |
| Disease | forced expiratory volume, response to bronchodilator | 2.05e-03 | 445 | 36 | 4 | EFO_0004314, GO_0097366 | |
| Disease | Necrosis | 2.06e-03 | 55 | 36 | 2 | C0027540 | |
| Disease | Intellectual Disability | 2.09e-03 | 447 | 36 | 4 | C3714756 | |
| Disease | triglycerides in LDL measurement | 2.14e-03 | 56 | 36 | 2 | EFO_0022320 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TMATAATTTTTTTAT | 6 | Q8N350 | |
| MEQVDEITTSTTTST | 181 | Q05D32 | |
| TTISTITSTITTGLM | 1021 | P51816 | |
| TSMESTVSSGTQTTV | 616 | Q9Y6D5 | |
| LTQTTVMETVTTVTT | 676 | P11532 | |
| ITEVTTMTSTVATES | 1711 | Q12830 | |
| VLTTTTTTVATGSMA | 2661 | Q9HC84 | |
| VLTTTTTTVATGSMA | 3361 | Q9HC84 | |
| VLTTTTTTVATGSMA | 4651 | Q9HC84 | |
| VTEEVTTTTTTITEK | 816 | Q01484 | |
| NVTTSTMEDTTISRS | 4861 | Q8WXI7 | |
| KTESTEMTITTQTGS | 9071 | Q8WXI7 | |
| MVTSLVTSSRAVTST | 11151 | Q8WXI7 | |
| EMSTSIMETTTTLAT | 311 | P58400 | |
| TSVSSTVSSTQTMVT | 511 | Q9Y5Z7 | |
| TMVIDATVTTTSTKD | 2351 | Q2M2H8 | |
| IISETTMASTTGSET | 171 | E2RYF6 | |
| TMASTTGSETATVST | 176 | E2RYF6 | |
| KVITASSMSSETTVA | 246 | E2RYF6 | |
| TTTVSITGTETTMVS | 356 | E2RYF6 | |
| TTTCTEGSEMTAVST | 666 | E2RYF6 | |
| TAVSATGSEMTTVST | 766 | E2RYF6 | |
| TTTSTEGSEMTTVST | 806 | E2RYF6 | |
| TTVSTTDSETTMVST | 896 | E2RYF6 | |
| TMVSTTGSERTITST | 906 | E2RYF6 | |
| TTVTTMGSETTTAST | 1216 | E2RYF6 | |
| TTASTTGSEMTTVFT | 1386 | E2RYF6 | |
| TGSEMTTVFTTVSET | 1391 | E2RYF6 | |
| STDTVINVITNMTTT | 121 | Q92484 | |
| LATATTVSITMASSV | 1726 | Q9UPA5 | |
| TVVTSVTSNMDSHES | 371 | Q9NQ69 | |
| MPVTVTRTTITTTTT | 1 | Q96S97 | |
| EMSTSIMETTTTLAT | 1316 | Q9ULB1 | |
| QSSSTSTSIIVSMVS | 161 | Q06495 | |
| ATTIMETTTTMATTT | 316 | P58401 | |
| FSMVASSVTTTESIK | 51 | P81408 | |
| TVLTMSTIITAVSAS | 306 | A8MPY1 | |
| KIVTEETMTTTTVTE | 816 | Q12955 | |
| SEITDMVRSSTITVS | 296 | P32019 | |
| ITSMSVSTTLVASSE | 631 | Q685J3 | |
| TTMVASSETSTLSTT | 1051 | Q685J3 | |
| DTVKIITSSVSGMTT | 506 | A6NES4 | |
| TTVLTTMTVSTTTSV | 176 | Q96D42 | |
| MILSTVTLITVSTVS | 526 | Q8WWX8 | |
| VSTMVTTSTTTTVAK | 1036 | A5YKK6 | |
| LVQSSSTSTSIVVSM | 156 | O95436 | |
| STSTSIVVSMVSSSL | 161 | O95436 | |
| ETTSTISTVSSMSTL | 1371 | Q9BYB0 | |
| DEETTTTTTIITTTI | 221 | Q53EL9 | |
| TVVSESAETMTASSS | 761 | P49790 | |
| MESSSVSVVSVVHDT | 316 | Q5SVZ6 | |
| LAERTMSVTTDSTVT | 1971 | Q6N021 | |
| QSVVTTSELSTMTVS | 656 | P18583 | |
| TEETTTSVEETTIST | 826 | Q9Y493 | |
| ESSETTTNTTTAKEM | 761 | O60237 |